Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl 3,4,5-trimethoxybenzoate is a chemical compound that falls under the category of organic compounds known as benzoic acid esters. It is an ester derivative of benzoic acid and is recognized as a plant metabolite. This aromatic ether is characterized by its molecular formula C13H18O5 and contains a benzoate ester within its structure. Ethyl 3,4,5-trimethoxybenzoate is utilized in various applications and research fields, but it is essential to consider appropriate safety measures due to its chemical properties.

6178-44-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6178-44-5 Structure
  • Basic information

    1. Product Name: Ethyl 3,4,5-trimethoxybenzoate
    2. Synonyms: RARECHEM AL BI 0063;3,4,5-TRIMETHOXYBENZOIC ACID ETHYL ESTER;ETHYL 3,4,5-TRIMETHOXYBENZOATE;3,4,5-Trimethoxybenzoic;Nsc26825;Benzoic acid, 3,4,5-triMethoxy-, ethyl ester
    3. CAS NO:6178-44-5
    4. Molecular Formula: C12H16O5
    5. Molecular Weight: 240.25
    6. EINECS: N/A
    7. Product Categories: Aromatic Esters
    8. Mol File: 6178-44-5.mol
  • Chemical Properties

    1. Melting Point: 54 °C
    2. Boiling Point: 168 °C / 6mmHg
    3. Flash Point: 123.4 °C
    4. Appearance: /
    5. Density: 1.113 g/cm3
    6. Vapor Pressure: 0.00189mmHg at 25°C
    7. Refractive Index: 1.492
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: Ethyl 3,4,5-trimethoxybenzoate(CAS DataBase Reference)
    11. NIST Chemistry Reference: Ethyl 3,4,5-trimethoxybenzoate(6178-44-5)
    12. EPA Substance Registry System: Ethyl 3,4,5-trimethoxybenzoate(6178-44-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: 24/25
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 6178-44-5(Hazardous Substances Data)

6178-44-5 Usage

Uses

Used in Chemical Research:
Ethyl 3,4,5-trimethoxybenzoate is used as a research compound for studying its chemical properties and potential applications in the field of organic chemistry. Its unique structure and characteristics make it a valuable subject for scientific investigation.
Used in Pharmaceutical Industry:
Ethyl 3,4,5-trimethoxybenzoate is used as an intermediate in the synthesis of various pharmaceutical compounds. Its presence in plant metabolites suggests potential biological activity, which can be harnessed for the development of new drugs.
Used in Flavor and Fragrance Industry:
Ethyl 3,4,5-trimethoxybenzoate is used as a flavoring agent and a fragrance ingredient in the production of food and cosmetic products. Its aromatic properties contribute to the creation of unique scents and flavors.
Used in Agrochemical Industry:
Ethyl 3,4,5-trimethoxybenzoate is used as a component in the formulation of agrochemicals, such as pesticides and herbicides. Its plant metabolite nature may provide insights into the development of more effective and environmentally friendly products.
Used in Material Science:
Ethyl 3,4,5-trimethoxybenzoate is used as a component in the development of new materials, such as polymers and coatings, due to its chemical properties. Its potential applications in material science can lead to the creation of innovative products with improved performance.

Check Digit Verification of cas no

The CAS Registry Mumber 6178-44-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,1,7 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6178-44:
(6*6)+(5*1)+(4*7)+(3*8)+(2*4)+(1*4)=105
105 % 10 = 5
So 6178-44-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O5/c1-5-17-12(13)8-6-9(14-2)11(16-4)10(7-8)15-3/h6-7H,5H2,1-4H3

6178-44-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A13199)  Ethyl 3,4,5-trimethoxybenzoate, 98%   

  • 6178-44-5

  • 5g

  • 236.0CNY

  • Detail
  • Alfa Aesar

  • (A13199)  Ethyl 3,4,5-trimethoxybenzoate, 98%   

  • 6178-44-5

  • 25g

  • 916.0CNY

  • Detail
  • Alfa Aesar

  • (A13199)  Ethyl 3,4,5-trimethoxybenzoate, 98%   

  • 6178-44-5

  • 100g

  • 3078.0CNY

  • Detail

6178-44-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 3,4,5-trimethoxybenzoate

1.2 Other means of identification

Product number -
Other names 3,4,5-Trimethoxy-benzoesaeure-aethylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6178-44-5 SDS

6178-44-5Relevant articles and documents

Acyl-functionalized molybdenum compounds [(η3-C3H5)(η5-Cp')Mo(CO)2]: An experimental study including the X-ray structure of a rare endo conformer

Schejbal, Ji?í,Honzí?ek, Jan,Vinklárek, Jaromír,Erben, Milan,R??i?ková, Zdeňka

, p. 5895 - 5907 (2014)

A series of new acyl-functionalized molybdenum(II) complexes [(η3-C3H5)(η5-C5H4COR)Mo(CO)2] have been successfully synthesized and crystallographically characterized, and the rel

New composition for improving skin conditions

-

Paragraph 0078-0080, (2020/07/30)

The present invention relates to a composition for improving skin condition which comprises a derivative of a compound represented by chemical formula (I) or a pharmacologically acceptable salt thereof. In the chemical formula (I), X is hydrogen or methoxy, and R is a C1 to C20 linear or branched alkyl group.COPYRIGHT KIPO 2020

HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER

-

Paragraph 00103; 00106; 00108, (2020/10/20)

Compounds which are thiazole and triazole derivatives are disclosed, including compounds of the following genus: Formula I. The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are useful in the treatment of a variety of disorders, including a fibrosis or a fibrotic disease, such as renal fibrosis.

Synthesis of Dithiolethiones and Identification of Potential Neuroprotective Agents via Activation of Nrf2-Driven Antioxidant Enzymes

Bai, Feifei,Fang, Jianguo,Song, Zi-Long,Zhang, Baoxin

, p. 2214 - 2231 (2020/03/06)

Oxidative stress is implicated in the pathogenesis of a wide variety of neurodegenerative disorders, and accordingly, dietary supplement of exogenous antioxidants or/and upregulation of the endogenous antioxidant defense system are promising for therapeutic intervention or chemoprevention of neurodegenerative diseases. Nrf2, a master regulator of the cellular antioxidant machinery, cardinally participates in the transcription of cytoprotective genes against oxidative/electrophilic stresses. Herein, we report the synthesis of 59 structurally diverse dithiolethiones and evaluation of their neuroprotection against 6-hydroxydopamine-or H2O2-induced oxidative damages in PC12 cells, a neuron-like rat pheochromocytoma cell line. Initial screening identified compounds 10 and 11 having low cytotoxicity but conferring remarkable protection on PC12 cells from oxidative-mediated damages. Further studies demonstrated that both compounds upregulated a battery of antioxidant genes as well as corresponding genes' products. Significantly, silence of Nrf2 expression abolishes cytoprotection of 10 and 11, indicating targeting Nrf2 activation is pivotal for their cellular functions. Taken together, the two lead compounds discovered here with potent neuroprotective functions against oxidative stress via Nrf2 activation merit further development as therapeutic or chemopreventive candidates for neurodegenerative disorders.

Differences in the Mechanisms of MnO2Oxidation between Lignin Model Compounds with the p-Hydroxyphenyl, Guaiacyl, and Syringyl Nuclei

Sun, Shirong,Akiyama, Takuya,Yokoyama, Tomoya,Matsumoto, Yuji

, p. 6819 - 6825 (2020/07/02)

The purpose of this study was to examine how the rate and mechanism of MnO2 oxidation differ between the p-hydroxyphenyl (H), guaiacyl (G), and syringyl (S) types of simple nonphenolic lignin model compounds as well as the p-ethylphenyl (E) type compounds. The oxidation was conducted using an excess amount of MnO2 in a sulfate buffer solution at a pH value of 1.5 at room temperature. MnO2 oxidized at least the G and S nuclei, although it commonly oxidizes alcohols present at the benzyl position. The oxidation rates of the benzyl alcohol derivatives were in the order of G- > S- ? H- > E-type, which suggests that the rates are determined by the electronic effects of their methoxy and ethyl functional groups on not only their benzyl positions but also their aromatic π-electron systems. The kinetic isotope effect was observed in the MnO2 oxidations of the same derivatives deuterated at their benzyl hydroxymethyl groups. The observed magnitudes were in the order of E- ? H- > G- ? S-type, suggesting that the contribution of oxidation of their aromatic nuclei, which is another reaction mode of the oxidation of their benzyl positions, increases in the reverse order.

New imidazo[2,1-: B] thiazole-based aryl hydrazones: Unravelling their synthesis and antiproliferative and apoptosis-inducing potential

Babu, Bathini Nagendra,Devi, Ganthala Parimala,Kamal, Ahmed,Kumar, C. Ganesh,Rani Routhu, Sunitha,Shareef, Mohd Adil

supporting information, p. 1178 - 1184 (2020/11/03)

Herein, we have designed and synthesized new imidazo[2,1-b]thiazole-based aryl hydrazones (9a-w) and evaluated their anti-proliferative potential against a panel of human cancer cell lines. Among the synthesized compounds, 9i and 9m elicited promising cytotoxicity against the breast cancer cell line MDA-MB-231 with IC50 values of 1.65 and 1.12 μM, respectively. Cell cycle analysis revealed that 9i and 9m significantly arrest MDA-MB-231 cells in the G0/G1 phase. In addition, detailed biological studies such as annexin V-FITC/propidium iodide, DCFH-DA, JC-1 and DAPI staining assays revealed that 9i and 9m triggered apoptosis in MDA-MB-213 cells. Overall, the current work demonstrated the cytotoxicity and apoptosis-inducing potential of 9i and 9m in breast cancer cells and suggested that they could be explored as promising antiproliferative leads in the future. This journal is

Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity

Mohammed, Hamada H.H.,Abdelhafez, El-Shimaa M.N.,Abbas, Samar H.,Moustafa, Gamal A.I.,Hauk, Glenn,Berger, James M.,Mitarai, Satoshi,Arai, Masayoshi,Abd El-Baky, Rehab M.,Abuo-Rahma, Gamal El-Din A.

, (2019/05/01)

New N-4-piperazinyl ciprofloxacin-triazole hybrids 6a-o were prepared and characterized. The in vitro antimycobacterial activity revealed that compound 6a experienced promising antimycobacterial activity against Mycobactrium smegmatis compared with the reference isoniazide (INH). Additionally, compound 6a exhibited broad spectrum antibacterial activity against all the tested strains either Gram-positive or Gram-negative bacteria compared with the reference ciprofloxacin. Also, compounds 6g and 6i displayed considerable antifungal activity compared with the reference ketoconazole. DNA cleavage assay of the highly active compounds 6c and 6h showed a good correlation between the Mycobactrium cleaved DNA gyrase assay and their in vitro antimycobactrial activity. Moreover, molecular modeling studies were done for the designed ciprofloxacin derivatives to predict their binding modes towards Topoisomerase II enzyme (PDB: 5bs8).

Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II

Verma, Garima,Khan, Mohemmed Faraz,Mohan Nainwal, Lalit,Ishaq, Mohd,Akhter, Mymoona,Bakht, Afroz,Anwer, Tariq,Afrin, Farhat,Islamuddin, Mohammad,Husain, Ibraheem,Alam, Mohammad Mumtaz,Shaquiquzzaman, Mohammad

, (2019/05/29)

In continuance with earlier reported work, an extension has been carried out by the same research group. Mulling over the ongoing condition of resistance to existing antimalarial agents, we had reported synthesis and antimalarial activity of certain pyrazole-1,3,4-oxadiazole hybrid compounds. Bearing previous results in mind, our research group ideated to design and synthesize some more derivatives with varied substitutions of acetophenone and hydrazide. Following this, derivatives 5a–r were synthesized and tested for antimalarial efficacy by schizont maturation inhibition assay. Further, depending on the literature support and results of our previous series, certain potent compounds (5f, 5n and 5r) were subjected to Falcipain-2 inhibitory assay. Results obtained for these particular compounds further strengthened our hypothesis. Here, in this series, compound 5f having unsubstituted acetophenone part and a furan moiety linked to oxadiazole ring emerged as the most potent compound and results were found to be comparable to that of the most potent compound (indole bearing) of previous series. Additionally, depending on the available literature, compounds (5a–r) were tested for their antileishmanial potential. Compounds 5a, 5c and 5r demonstrated dose-dependent killing of the promastigotes. Their IC50 values were found to be 33.3 ± 1.68, 40.1 ± 1.0 and 19.0 ± 1.47 μg/mL respectively. These compounds (5a, 5c and 5r) also had effects on amastigote infectivity with IC50 of 44.2 ± 2.72, 66.8 ± 2.05 and 73.1 ± 1.69 μg/mL respectively. Further target validation was done using molecular docking studies. Acute oral toxicity studies for most active compounds were also performed.

Synthesis and biological evaluation of novel disulfides incorporating 1,3,4-thiadiazole scaffold as promising antitumor agents

Li, Sha,Wang, Hai-Xin,Liu, Hai-Ying,Jing, Fen,Fu, Xiao-Yun,Li, Cai-Wen,Shi, Yan-Ping,Chen, Bao-Quan

, p. 1502 - 1508 (2019/07/30)

In the present study, fourteen 2,5-disubstituted 1,3,4-thiadiazole derivatives containing disulfide group were prepared. The resulting compounds 7a–7n were identified by IR, NMR, MS, and elemental analysis. Their antiproliferative properties in vitro were studied employing standard CCK-8 assay against SMMC-7721, MCF-7, and A549 lines. Bioassay indicated that some compounds showed stronger antitumor effects than reference drugs PX-12 and 5-fluorouracil. Among these screened compounds, compound 7h showed excellent biological activities in inhibiting SMMC-7721 cell proliferation with IC50 at 1.93 ± 0.08 μM. Compounds 7k and 7i manifested highly effective growth inhibitory activity versus MCF-7 cells, with IC50 at 3.04 ± 0.09 and 3.54 ± 0.17 μM, respectively. For A549 cells, compound 7m was found to have the highest antitumor potency with IC50 at 3.67 ± 0.13 μM.

Synthesis, molecular docking, antimicrobial evaluation, and DNA cleavage assay of new thiadiazole/oxadiazole ciprofloxacin derivatives

Mohammed, Hamada H. H.,Abbas, Samar H.,Abdelhafez, El-Shimaa M. N.,Berger, James M.,Mitarai, Satoshi,Arai, Masayoshi,Abuo-Rahma, Gamal El-Din A. A.

, p. 1809 - 1824 (2019/11/05)

Abstract: Herein we report the synthesis of new N-4-piperazinyl thiadiazole and oxadiazole ciprofloxacin derivatives and their antibacterial and antimycobacterial activities. Although thiadiazole ciprofloxacin derivatives compound showed broad spectrum antibacterial activity against all the tested strains either Gram-positive or Gram-negative organisms, the oxadiazole derivatives exhibited weaker antibacterial and antimycobacterial activities than thiadiazole derivatives against most of the tested strains compared with the reference ciprofloxacin. Moreover, the antimycobacterial screening revealed that compounds which containing thiadiazole scaffold potently inhibited Mycobacterium smegmatis at MIC of 1.56 and 3.13, respectively, and modestly inhibited the drug-resistant strains. DNA cleavage assay revealed that thiadiazole ciprofloxacin derivatives inhibited supercoil relaxation, albeit to a lesser extent than ciprofloxacin, and it also increased the amount of nicked substrate produced. Graphic abstract: [Figure not available: see fulltext.].

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6178-44-5